je.st
news
Merck Highlights Ongoing Commitment to Fighting Infectious Diseases with More than 30 Data Presentations at ASM Microbe 2016
2016-06-15 14:30:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that researchers are scheduled to provide more than 30 scientific data presentations on the companys established and investigational infectious disease medicines and vaccines at the American Society for Microbiologys ASM Microbe 2016 meeting in Boston, June 16-20. Language: English Contact: Media:Pamela Eisele, 267-305-3558Robert Consalvo, 908-295-0928Investor:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: data
commitment
highlights
ongoing
Category:Biotechnology and Pharmaceuticals